SEC Form 4 · accession 0000899243-16-011724
NovoCure Ltd · NVCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Wilhelmus Cm Groenhuysen
Officer — Chief Financial Officer
Period of report
Jan 12, 2016
Accepted (ET)
Jan 14, 2016 · 8:32 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001645113
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options to Buy Ordinary SharesF1 | $21.90 | Jan 12, 2016 | A | 450,000 | A | — | Jan 12, 2026 | Ordinary Shares | 450,000 | 450,000 | D |
Explanation of responses
- F1Options to buy 450,000 ordinary shares will vest and become exercisable in equal installments on each of January 1, 2017, 2018, 2019 and 2020, subject to Mr. Groenhuysen's continued employment through such dates.